ABCB1 and chronic myelogenous leukemia, BCR-ABL1 positive: To evaluate the joint effect of double combinations of SNPs on CML susceptibility and CCyR to imatinib, we considered TT/CT genotype as a reference genotype, according to the recessive model for ABCB1 SNPs.